Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Duffy

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Nature Communications|January 12, 2021
Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response BoxJanette Reader, Mariëtte E van der Watt, Dale Taylor, et al.
Journal of Medicinal Chemistry|June 1, 2025
Optimization of Tambjamines Active against Multiple Stages of Malaria ParasitesAmrendra Kumar, Yuexin Li, Xiaowei Zhang, et al.
ACS Infectious Diseases|November 11, 2024
Tambjamines as Fast-Acting Multistage AntimalarialsAmrendra Kumar, Yuexin Li, Rozalia A Dodean, et al.
Journal of Medicinal Chemistry|February 12, 2021
Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite <i>Plasmodium falciparum</i> and Optimization EffortsClaire Le Manach, Jean Dam, John G Woodland, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of MalariaChristel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2018
Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria"Christel Brunschwig, Nina Lawrence, Dale Taylor, et al.
NPJ Drug Discovery|March 11, 2025
Revisiting the <i>Plasmodium falciparum</i> druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.
Science Advances|December 6, 2024
Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmissionPaula-Josefina Gomez-Gonzalez, Antima Gupta, Laura G Drought, et al.
Research Square|December 9, 2024
Revisiting the Plasmodium falciparum druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.
Nature Reviews. Drug Discovery|December 15, 2021
IMI European Lead Factory - democratizing access to high-throughput screeningPhilip S Jones, Sylviane Boucharens, Stuart P McElroy, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Nature Communications|January 12, 2021
Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response BoxJanette Reader, Mariëtte E van der Watt, Dale Taylor, et al.
Journal of Medicinal Chemistry|June 1, 2025
Optimization of Tambjamines Active against Multiple Stages of Malaria ParasitesAmrendra Kumar, Yuexin Li, Xiaowei Zhang, et al.
ACS Infectious Diseases|November 11, 2024
Tambjamines as Fast-Acting Multistage AntimalarialsAmrendra Kumar, Yuexin Li, Rozalia A Dodean, et al.
Journal of Medicinal Chemistry|February 12, 2021
Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite <i>Plasmodium falciparum</i> and Optimization EffortsClaire Le Manach, Jean Dam, John G Woodland, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of MalariaChristel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2018
Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria"Christel Brunschwig, Nina Lawrence, Dale Taylor, et al.
NPJ Drug Discovery|March 11, 2025
Revisiting the <i>Plasmodium falciparum</i> druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.
Science Advances|December 6, 2024
Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmissionPaula-Josefina Gomez-Gonzalez, Antima Gupta, Laura G Drought, et al.
Research Square|December 9, 2024
Revisiting the Plasmodium falciparum druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.
Nature Reviews. Drug Discovery|December 15, 2021
IMI European Lead Factory - democratizing access to high-throughput screeningPhilip S Jones, Sylviane Boucharens, Stuart P McElroy, et al.
Pageof 7